Valencia, Spain

Carlos Simón

This inventor holds 1 USPTO granted patent and 4 published patent applications and 2 EPO patents. Top assignee: Igenomix S.l.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carlos Simón. Retrieved from https://idiyas.com/inventor/carlos-simon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Carlos Simón: Innovator in Stem Cell Therapy

Introduction

Carlos Simón is a prominent inventor based in Valencia, Spain. He has made significant contributions to the field of regenerative medicine, particularly in the area of stem cell therapy. His innovative work focuses on treating endometrial pathologies, which has the potential to improve the quality of life for many women.

Latest Patents

Carlos Simón holds a patent for his invention titled "Stem cell therapy in endometrial pathologies." This invention relates to the use of autologous CD133+ bone marrow stem cells (BMDSC) to induce endometrial regeneration and treat conditions such as Asherman's syndrome and endometrial atrophy. The patent outlines methods for administering an effective amount of these stem cells into the uterine arteries of a subject in need, promoting endometrial regeneration.

Career Highlights

Throughout his career, Carlos Simón has worked with notable companies in the field of reproductive health. He has been associated with Igenomix S.L. and Asherman Therapy S.L.U., where he has contributed to advancing research and clinical applications in stem cell therapy.

Collaborations

Carlos has collaborated with esteemed colleagues, including Xavier Santamaria and Irene Cervelló. Their combined expertise has furthered the development of innovative solutions in the realm of reproductive medicine.

Conclusion

Carlos Simón is a key figure in the advancement of stem cell therapy for endometrial pathologies. His innovative patent and collaborative efforts highlight his commitment to improving women's health through scientific research and application.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…